Setup

Burford Capital (BUR) is the largest publicly-traded litigation finance pure-play. On March 27, 2026, the Second Circuit reversed its $16.1B YPF judgment — Burford's largest single asset. The stock collapsed to $4.14 on RSI 13.5 and 20.6x normal volume. Wedbush downgraded to Neutral on May 11, one day before Q1 earnings. The Q1 2026 print (May 8) and a peer's secondary transaction (FY2025) materially reframe the post-event setup.

What the filing and corroboration say

Liquidity was pre-positioned. BUR raised $500M of senior notes in January 2026 — two months before the YPF ruling — and simultaneously redeemed remaining 2026 UK bonds. Q1 ended with $740M cash + marketable securities, no debt maturities until 2028, and all maintenance covenants eliminated.

Covenant constrained, not threatened. 144A indentures have an incurrence test at 2.0x debt-to-equity; current D/E is 3.5x. BUR cannot issue new net debt but has no maintenance covenants and zero default risk. Growth must be funded organically.

Core business is accelerating. Q1 2026 new commitments $133M (+25% vs Q1 2024-25 average). Unfunded definitive commitments >£1B (+40% vs Q4 2024). 36 trials/hearings scheduled in 2026 vs 23 at same point last year (+57%). 23 assets with $10M+ realization potential in 2026 vs 14 actually delivered in 2025. $280M+ cash visibility for 2026.

Marks are deeply conservative — externally validated. BUR balance sheet ROIC: 22%. Historical concluded ROIC: 82%. Cumulative realized loss rate ≈10%, "remarkably consistent" over 11 years. Modeled non-YPF realizations: $5.2B (reaffirmed unchanged).

The single most important external data point: Omni Bridgeway (OBL.AX) Fund IX secondary transaction (FY2025) priced at ≈100% of fair value carrying with 3.2x MOIC on deployed capital. A third-party institutional buyer paid clearing prices that validated the litigation-finance marking model at a directly-analogous comp. The 60-point gap between balance sheet ROIC and concluded ROIC is a sector-structural feature of the accounting model, not BUR-specific narrative.

YPF path forward is BIT arbitration. En banc petition filed May 8 (CEO: "realistically difficult to obtain"). Real path: ICSID under Spain-Argentina (Petersen) and US-Argentina (Eton Park) treaties. Per UNCTAD, Argentina has lost 26 of 32 contested ICSID awards (81%); counting settlements, ≈86%. Cost $10-20M. Timeline ≈6+ years. Confidential.

What the market thinks

≈$1.0B market cap on ≈220M diluted shares, trading at 30% of $13.60 non-YPF book per share. Mean analyst target $9.09; Wedbush at $5 (downgraded May 11). Forward P/E 5.79.

Options structure: P/C ratio 0.21 (bullish), ATM IV 52% at 22nd percentile (cheap), max pain $5.00. Jan 2028 LEAPS P/C 0.10 — calls outpacing puts ≈10:1.

Pre-event factor regression (120-day, R²=26%): β_SPY=0.74, β_KCE=0.68 (t=3.0). ARGT loading is 0.16 and statistically insignificant (p=.12) — the market has not priced BIT arbitration optionality. No meaningful momentum loading.

Probability-weighted scenario ladder (5y horizon, per-share):

E[V] = $10.58. Upside ≈131% to E[V] over 3-5 years → ≈18% gross CAGR. Spanned factor return ≈10.7%, so α_orth ≈7-13% annualized. α/σ_idio ≈ 0.20-0.35 SR units — well within Paleologo bound.

Why the gap exists

1. Forced-seller dynamics not yet reversed. March 27 saw RSI 13.5 on 20.6x volume — index and credit-overlay funds dumping into illiquidity. Sell-side capitulated after the bottom (Wedbush May 11 cut, one day before earnings). Counterparty is uninformed or constrained.

2. Cross-ticker validation un-synthesized. OBL.AX is Australian, illiquid in the US, and reports on a different fiscal calendar. The Fund IX secondary print is the single load-bearing external comp; US sell-side has not connected it to BUR's marks.

3. Sector abandonment. Litigation finance is a category institutional capital wrote off post-PACCAR. UK reversal is in motion but slow. No new investor cohort bidding for BUR.

4. YPF dominates the narrative. The $16.1B headline obscures the $5.2B non-YPF model. CEO explicitly said "close that chapter, turn the page" — analysts remain anchored to YPF as a percentage of value when it's now optionality only.

5. Argentina BIT optionality priced at zero. Confirmed by ARGT regression (insignificant loading). The 81% Argentina BIT loss rate is public and verifiable; the market hasn't synthesized it into BUR's residual value.

Risks (ranked)

1. Mark integrity tail. If two or more $50M+ non-YPF cases rule adversely in a 60-day window, the modeled $5.2B compresses. 237 assets help; value-weighted concentration is unknown.
2. Slow re-rate. DEMAND factor with 365d+ half-life. Patience required; momentum holders exit if no print in 6 months.
3. Covenant constraint caps growth. 3.5x D/E vs 2.0x incurrence = cannot lean balance sheet into the opportunity.
4. Regulatory tail. US federal anti-litigation-finance legislation (low base rate). UK PACCAR reversal stalls.
5. YPF arbitration disappoints. Argentina settles for nuisance OR ICSID rules narrowly. Eliminates the tail.
6. Idio vol. 37% pre-event annualized idio vol; survival sizing, not alpha sizing.

Catalysts

What would change our mind

Bearish:

• Q1 10-Q shows non-YPF FV <$2.5B consolidated (invalidates the marks claim)
• Two or more $50M+ non-YPF case losses in any 60-day window
• CEO or CIO insider open-market sale (Form 4 P-code in reverse)
• Auditor concerns in any quarterly filing
• OBL.AX or peer reports adverse realizations vs FV carrying within 12 months

Bullish (further):

• Second comparable secondary at par + MOIC>2x in next 12 months
• BIT arbitration formally filed before Q4 2026
• Cluster of insider open-market purchases (Form 4 P-code, $500K+ each)
• Dividend cut announced (counter-intuitively bullish; signals serious de-lever)

Evidence

LR: 1.4